MVIS® US Listed Pharmaceutical 25 Index

The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Country and Sector Weightings

MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.

CountryComponentsWeight
Canada1 0.76%
United States13 55.11%
Denmark1 4.54%
France1 4.77%
Ireland2 5.43%
Netherlands1 3.94%
Switzerland1 5.06%
United Kingdom4 10.23%
Israel1 5.41%
Japan1 4.76%
Total26 100.00%
SectorComponentsWeight
Consumer Staples1 1.42%
Health Care25 98.58%
Total26 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap2,753,933,038,000 USD22 96.30%
Mid-Cap10,815,770,400 USD3 3.44%
Small-Cap575,661,800 USD1 0.26%
Micro-Cap---
Total2,765,324,470,200 USD26 100.00%
Up